This is an erratum to the published paper titled“Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts”.We have discovered that Reference 4 was cited incorrect...
BACKGROUND Globally,prostate cancer has become a major threat to men's health,with an increasing incidence and causes serious effects on the quality and length of life of patients.Despite the rapid development of medi...
the Major Project of Science and Technology Foundation of Guizhou Provincial Health Commission,No.gzwkj2023-579;Zunyi Medical University Innovation Project,No.S202310661123.
BACKGROUND Prostate cancer(PCa)has high morbidity and mortality rates in elderly men.With a history of thousands of years,traditional Chinese medicine derived from insects could be an important source for developing c...
BACKGROUND Prostate cancer(PC)is one of the most common malignant tumors in men,and bone metastasis is one of its common complications,which seriously affects the quality of life and prognosis of patients.AIM To inves...
BACKGROUND Prostate cancer is the second most common cancer among men worldwide,and prostate-specific antigen(PSA)is often used in clinical practice to screen for prostate cancer.Normal total PSA(tPSA)level initially ...
Neuroendocrine prostate cancer(NEPC)shows an aggressive behavior compared to prostate cancer(PCa),also known as prostate adenocarcinoma.Scanty foci in PCa can harbor genetic alternation that can arise in a heterogenei...
Supported by Key Research and Development Projects in Hebei Province,No.21377795D;Natural Science Foundation of Hebei Province,No.H2021307017.
BACKGROUND Multiple primary malignant tumors(MPMTs)are rare type of cancer,especially when solid tumors are the first and lymphoma is the second primary malignancy.We report a patient with heterochronous MPMTs consist...
Supported by Suzhou Science and Technology Project,No.SYS2019053.
BACKGROUND Prostate cancer(PCa)is a widespread malignancy,predominantly affecting elderly males,and current methods for diagnosis and treatment of this disease continue to fall short.The marker Ki-67(MKI67)has been pr...
This article enthusiastically explores the study of highly aggressive variant prostate cancer(AVPC),acknowledging its relatively rare yet highly menacing presence within the realm of prostate cancer.The paper delves i...
Guangdong Provincial Hospital of Traditional Chinese Medicine,NO 2022KT1166 and NO 2018KT1635;Guangdong Provincial Bureau of Traditional Chinese Medicine,NO 2021KT1500;Guangzhou Science and Technology Bureau,NO 202201020350.
BACKGROUND Aggressive variant prostate cancer(AVPC)is a rare disease that progresses rapidly.The first-line treatment for AVPC is currently unknown.We examined a rare case of AVPC with rare brain and bladder metastase...